Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied
Clinical trial NCT03639675 · COMPLETED
Trial details
- NCT number
- NCT03639675
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-03
- Primary completion
- 2019-02-14
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.